How Is Bitcoin Marketing Itself

As a result of the Greek economic downturn and financial crisis as a whole, Bitcoin found itself at the centre of the news debate. Due to its natural characteristics, its decentralised platform, and ultimately its fascinating make-up due to the blockchain technology on which it is based, Bitcoin offers an exciting new wealth of opportunities. With the development of the bitcoin gambling casino which has introduced provably fair gaming to the online world and implementation by brands such as Subway and Steam, the cryptocurrency is continuing to grow. Despite numerous restrictions being placed on Bitcoin, the debate around its potential is continuing, and in turn the cryptocurrency has begun to market itself. Here, we’re taking a look at how.

The Characteristics Of Bitcoin

There are numerous exciting opportunities which Bitcoin provides, and a lot of these come from the characteristics behind the blockchain technology which makes up the cryptocurrency. Firstly, the decentralised element to the Bitcoin offers numerous advantages which is actually leading to disrupt numerous financial institutions. Despite its unpredictability and its evolution under the auspices of a nebulous entity, it is this challenging nature which is actually attracting numerous investors. The cryptocurrency is almost completely anonymous, and as such, many users feel protected when making purchases.

The blockchain technology itself is also exceptionally secure, with fraud being somewhat deterred by the make-up of the cryptocurrency. All of these characteristics have gradually marketed themselves, and with the boom in investment, more individuals are turning to this cryptocurrency as an alternative payment method.

Price Performance

A major indicator of the cryptocurrency’s growth is its price performance, and with the huge amount of investment going into the currency in recent months, it’s unsurprising to see that the price has boomed. Despite many critics believing that the currency remains unstable, the Bitcoin is marketing itself as a well-performing investment opportunity for many. While many are concerned about the regulations which are beginning to be imposed, these will only stabilise the cryptocurrency, further opening opportunities for use.

 

Fear By Financial Institutions

One of the major marketing aspects for Bitcoin is the fear it has imposed in some traditional financial institutions, which may now have to evolve their techniques in order to keep up with this ever-growing technology. While traditional financial institutions may see this as a negative, consumers and individuals will see this as a positive, as banks will now have to adapt their methods in order to keep funds as secure, yet accessible, as possible. Some financial institutions, such as Barclays, have already started to adopt cryptocurrency and blockchain technology, and have begun discussions with regulators on how to bring this technology into play more efficiently. With big brands such as these, alongside the likes of Subway, Microsoft, PlayStation and more embracing this technology, Bitcoin is being marketed in more ways than ever before.

While many associate Bitcoin with having an image issue, in modern times, this is very much the opposite. With increasing regulations being implemented, Bitcoin is only going to stabilise more efficiently, and as a result grow with more investments. Since the boom, Bitcoin’s marketing has been handled by the news and simply by word-of-mouth.

Checkout Unique Finance and get a bonus from me.

Managing Your Personal Finances the Smart Way

 

As a working adult in today’s economy, you will realize that managing personal finances is essential for survival. The cost of living is at an all-time high, there is more to spend on and less ways to make it. If you are not careful, you may end up living from pay check to pay check or worse, in debt! Saving is an essential part of managing personal finances that most people often fail at leading to financial strain in case of emergencies. The following are some of the ways you can improve your personal finances and save more:

Where are you financially

Start by knowing your financial status today. Financial status consists of a couple of factors:

  • How much you owe
  • How much you spend
  • How much you earn
  • How much you have in savings

You may need about a month to capture all the above information. Make sure you get all the credit card payments, bills, purchases and loans in order to determine where you are financially. Once you have a clear picture of your money, you can start making the decisions that will improve your financial status.

Determine your financial goals

It is quite difficult to have a plan if you do not have an end result in mind. You need to determine your monetary goals and develop a plan to meet these goals. Do you want to buy a new house? A new car? Start a business? You need to save up for short term or long term goals. Therefore, list down your needs in terms of urgency in order to avoid financially stressing yourself, buying expensive things that you do not presently need. Add up the costs of everything you need and this becomes your target savings for both long term and short-term needs. This is capital expenditures projection.

Cut back

Once you already know what you need, you should go back to your recorded spending and cut back on all unnecessary things. Unnecessary expenditures include things like magazine subscriptions that you never even read and cable TV that you never watch. Every dollar you cut back on is a dollar towards your goals. Websites like leasequit.com help you terminate your car lease early hence saving you money.

Once you are through cutting back, create a new monthly budget with only necessary expenditures and savings.

Jump start your savings

By now you are itching to start saving. Relax; you have already covered about 50% of the savings. Saving involves a lot of discipline and you might need to start avoiding hanging out with those friends that you often spend a lot of money with just to get your savings going. Here are some tips to jumpstart saving:

  • Open a saving account and set up an automatic savings transfer on a monthly basis.
  • You can also use direct deposit to move money from your salary straight to your savings.
  • Use your workplace’s 401(k) plan. 401(k) is a profit sharing plan offered by employers for employees.
  • Join a retirement benefits scheme.

Young woman covering her face with a 50 Euro note

Checkout Unique Finance and get a bonus from me.

How to recognize a good investment opportunity

 

A series of good investments can fund your ideal lifestyle, allowing you to retire sooner than expected or walk away from a job you dislike. Alternatively, bad investments can deplete your savings and damage your prospects for the future.

Knowing the difference between the two and finding the right opportunities at the right time is never straightforward, but knowing what to look out for when it comes to a potential investment – as well as what to avoid – can go a long way towards making sure your money always works in your favor.

Long-term viability

If you are risk-averse, you should confine your investments to those stocks and shares that you will be happy to own for at least ten years. While fields such as cryptocurrency may provide the opportunity to make large sums of money in a short amount of time, the best investments are those which provide solid returns and allow you to reinvest your dividends, either into the same company or into a more diverse portfolio.

Therefore, if the business or area you are thinking of investing in seems like a flash in the pan affair or temporary fad, you should proceed with extreme caution. That said, it’s important to factor in a plan to deal with any regrets you might have about an investment well in advance. This can include the regret that comes with making a loss but also the regret that comes with seeing an investment grow in value after you made the decision not to get involved. Dealing with the emotional ups and downs of investing at an early stage can make it easier for you to stay on track.

Alternative markets

Old standards such as property are likely to remain a good investment, especially if you are in for the long haul, but there are also a number of new ventures that offer a good return and a low level of risk, such as the growing field of peer to peer lending – a system in which investors provide the capital that is loaned out to businesses looking for cash injections.

One of the key advantages of peer to peer lending is that you can be actively involved in deciding exactly who you want to lend to. You can also share the risk with others by investing less than the full amount. Firms such as Folk2Folk.com only lend to those who can provide an adequate level of security, further reducing any risk to their investors.

Simple business models

While investing in the latest innovations and trends may provide great opportunities for some, if you invest in an area of business in which you have little understanding, it will be far more difficult for you to judge the market conditions and know when it’s a good time to cash in your shares or purchase more.

If you find a business that has a very simple business model that you fully understand, such a business is likely to operate in a more stable manner and have a solid growth curve at its core. Although the returns may not be as spectacular, investing in such a field will also provide you with far greater peace of mind, in addition to an additional income stream.

Checkout Unique Finance and get a bonus from me.

Bitcoin The Hottest Topic in World Currency

 

Bitcoin surged to a fresh all-time high on Thursday hitting $5,231, eclipsing the previous record of $5,014 hit in early September. The cryptocurrency is now up more than 420% for the year.  So far, investors and customers have shrugged off negative commentary about cryptocurrencies, despite being unable to break into the U.S. markets.

In September, Chinese authorities banned exchanges that deal in crypto currencies. They also banned initial coin offers which are the way most digital currencies raise capital. This has further perpetuated the rally, since there is a limited supply on the amount of a crypto currency that can be mined. With supply contained by regulators and demand increasing, the price of bitcoin is getting forced higher.

There have been reports floating during the past week that China might allow cryptocurrency exchange as well as ICOs. Sources cite Chinese regulators saying that bitcoin trading will likely resume with more regulation. This could include new licensing and anti-money laundering regulations.

SEC Does Not Give Its Blessing to Bitcoin

To date, the Securities and Exchange Commission (SEC), which is the main U.S. securities regulator, has not given its blessing to crypto currencies. Without consent from the SEC mainstream trading is not possible. Their unwillingness to consider bitcoin has frustrated exchange applicants who are now withdrawing their applications. This will likely be a long process, and need consent from congress as a new currency that is potentially subject to manipulation, would undermine the U.S. dollar. Bitcoin is a treat to the greenback globally, which will make it difficult for the digital currency to gain widespread acceptance in the United States.

Swedish Officials Pay Debt in Bitcoin

Swedish regulators with the Swedish Enforcement Authority has paid a debt with bitcoin. This is the first time the enforcement agency in any country has accepted bitcoin as a currency that is paid directly to a government.

Swedish authorities see bitcoin as an asset that can be used to make payment and its increasing acceptance will provide an alternative method for payments of debt. While the Swedish authorities are used to handling these issues through the banking world, they also take payments which need to be converted into cash.  By taking bitcoin, they greatly enhanced their ability to retrieve debts. In this regard, it seems the Swedish Enforcement Authority will likely continue accepting bitcoin for debts citizens wish to settle.

 

Bitcoin prices have broken out to fresh all-time highs pushing through the highs made in September, and poised to test higher levels.  Support on Bitcoin is seen near the 10-day moving average at 4,576.  Volume on the breakout is average, which does not add to the accelerating in prices.  Bitcoin prices are experiencing accelerating positive momentum as reflected by the relative strength index (RSI). The index is a momentum oscillator that also measures overbought and oversold levels. The currency reading on the RSI is 75, which is above the overbought trigger level of 70, which could foreshadow a correction. Reading below 30 on the RSI are considered oversold.

 

Checkout Unique Finance and get a bonus from me.

How to Start a Successful Fintech Company

Starting a fintech company has the potential to become a lucrative venture. However, for every successful fintech company, there are many other similar businesses that fail. To avoid this situation, you should follow the tips below so that the fintech business you establish has a much better chance of succeeding.

Education and Training

Before you start a fintech business, you need to understand how business and finance work. In order to build this foundation, you should complete a relevant finance-related course, such as the online master of financial economics degree program offered by universities like Ohio University. An online MFE degree or similar course will equip you with the financial and business skills and knowledge required to become a leader in your chosen fintech area.

Focus on Your Goal

Today, there are many different types of Fintech businesses you could start including companies that deal with financial billing, payments, financial advice, business tools and integration with other financial systems. Unfortunately, many entrepreneurs jump from one business idea to another and eventually end up going around in circles and never achieve anything in their business careers.

To avoid this situation, you need to stay completely focused on the idea you intend to turn into a fintech business. The more you focus on your business idea in this way, the more you will understand the area you intend to work in and the more likely it is that you will eventually develop a much stronger, more effective company.

Attracting Investment

When you start a fintech business, it’s going to cost a lot of time and money to get it up and running. Most fintech startup owners have all the time in the world, but normally they don’t have the capital required to get their new business idea off the ground.

If you don’t have access to enough startup capital, it’s essential to try and attract investors who do have money. This exercise needs to be done in a professional and business-like fashion, which means you need to produce a comprehensive business plan and know all of your facts and figures before approaching any investor.

In many cases, investors will be investing more in you and your personality as much as they will be investing in your business idea, so you need to be organized, confident, and professional at all times. If you can do this, you will be much more likely to obtain the funding you need for your startup.

Build a Professional Team

The people who work with you will determine how successful your new venture becomes. From the start, you need to surround yourself with people who know what they’re doing and have the skills and experience required for a top-quality job.

Teamwork should also be a priority. As the driving force behind your new Fintech company, you need to develop a positive business culture amongst your team members.

As you can see, there are many factors you need to address before you start a fintech company. However, it’s not an impossible task and following the steps above will ensure that you are more likely to succeed with your new company.

Checkout Unique Finance and get a bonus from me.

Med-X Inc. Resumes Equity rowdfunding

Medical cannabis-focused Med-X, Inc. has resumed its equity crowdfunding campaign through StartEngine.com in a bid to raise $14.1 million through a minimum $420 per 700 shares.The manufacturer of non-toxic insecticide and pesticide for marijuana cultivators and publisher of The Marijuana Times relaunched the campaign on Sept. 28, 2017 following the lifting of its Securities and Exchange Commission temporary suspension arising from a late filing last year.“We have been qualified by the SEC and believe we are in full compliance to resume our Regulation A+ crowdfunding efforts once again,” said Chief Operations Officer Matthew Mills.

 

Med-X Inc. became the first cannabis company to launch a Regulation A+ equity crowdfunding campaign provided in the 2012 JOBS Act. It is also the first company involved with cannabis that StartEngine allowed to raise capital through its platform.”They let us jump on their platform, as we agreed not pursue handling the plant until it’s legal to do so,” said Mills. Mills said FundAmerica is handling the campaign that has raised under $1 million so far.The management team has been diligently working on its business model and continues positioning the company in accordance with its initial plan of operations.”The primary focus will be on the Nature-Cide product line for natural pest control in cannabis cultivation, along with the continued development of the popular online cannabis industry publication, The Marijuana Times,” according to Mills.

 

Nature-Cide

With cities in California and other states legalizing marijuana cultivation and manufacturing, the number of legal indoor pot farms and manufacturing sites for edible products is expected to increase driving demand for improving the quality and safety of local marijuana.Med-X has begun supplying Nature-Cide Pest Management and All-Purpose formulations to the cannabis agricultural and provisioning industries. It is also preparing for distribution its newly developed Nature-Cide insecticidal soil product for all types cultivators. The formulations are a proprietary all-natural essential oil insecticide/miticide/nematicide that repels and kill a wide variety of pests commonly known to damage cannabis crops. Nature-Cide products are listed on the “Approved for use in the Cultivation of Marijuana” by the Colorado, Washington and Oregon state Agriculture Departments. The listing is supported by Med-X’s 18-Month Nature-Cide Integrated Pest Management (IPM) for Cannabis Cultivation Report released in March. “The 18-month report began in 2015 shortly after realizing that the Nature-Cide pesticide products were being recognized by multiple state agricultural departments as a product that is approved for use in medical and recreational marijuana cultivation,” said Mills.

 

Growth advantage

 The legal cannabis industry grew 30 percent in 2016 in North America alone to reach to $6.7 billion because of high growth prospects in the U.S. and Canada, data from Arcview Market Research showed. Arcview is projecting a 25 percent annual growth rate with sales in North American reaching $20.2 billion by 2021. Med-X is in great position to take advantage of the opportunities in the legal cannabis space.While primarily in the business of research and development of commercial medicinal applications of cannabis, Med-X Inc. plans to address other needs required to support the fast-paced emerging cannabis industry, including compound identification and extraction from cannabis oils, along with pharmacy automation beginning with cannabis products and eventually for various pharmaceuticals.According to its SEC filings, Med-X Inc. plans to cultivate and sell high-quality cannabis for the consumer and commercial markets in areas where it is legal and when they are fully licensed to do so. “Due to our management’s hands-on background in the fields of medicine, large-scale cultivation, commercial pest management as well as operations in internet-based wholesale and retail outlets, we feel we have a tremendous advantage, and can use that skill set to climb into a growth position more rapidly than most,” said Mills.

 

About Med-X, Inc.

 Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compound for the present medical industry demand. The company’s digital magazine, The Marijuana Times, publishes quality media content for the medical cannabis community to generate revenue from advertisers as well as sell industry related merchandise to consumers. The company is ready to bring various products to market in the cannabis, agricultural and ancillary services industries through manufacturing partnerships. For more information regarding Med-X, Inc., please visit www.medx-rx.com, email info@medx-rx.comor call 818-349-2870.

 

Checkout Unique Finance and get a bonus from me.

Med-X Inc. Resumes Equity Crowdfunding

 

Medical cannabis-focused Med-X, Inc. has resumed its equity crowdfunding campaign through StartEngine.com in a bid to raise $14.1 million through a minimum $420 per 700 shares.

The manufacturer of non-toxic insecticide and pesticide for marijuana cultivators and publisher of The Marijuana Times relaunched the campaign on Sept. 28, 2017 following the lifting of its Securities and Exchange Commission temporary suspension arising from a late filing last year.

“We have been qualified by the SEC and believe we are in full compliance to resume our Regulation A+ crowdfunding efforts once again,” said Chief Operations Officer Matthew Mills.

 

Med-X Inc. became the first cannabis company to launch a Regulation A+ equity crowdfunding campaign provided in the 2012 JOBS Act. It is also the first company involved with cannabis that StartEngine allowed to raise capital through its platform.

“They let us jump on their platform, as we agreed not pursue handling the plant until it’s legal to do so,” said Mills.

Mills said FundAmerica is handling the campaign that has raised under $1 million so far.The management team has been diligently working on its business model and continues positioning the company in accordance with its initial plan of operations.

“The primary focus will be on the Nature-Cide product line for natural pest control in cannabis cultivation, along with the continued development of the popular online cannabis industry publication, The Marijuana Times,” according to Mills.

 

Nature-Cide

With cities in California and other states legalizing marijuana cultivation and manufacturing, the number of legal indoor pot farms and manufacturing sites for edible products is expected to increase driving demand for improving the quality and safety of local marijuana.

Med-X has begun supplying Nature-Cide Pest Management and All-Purpose formulations to the cannabis agricultural and provisioning industries. It is also preparing for distribution its newly developed Nature-Cide insecticidal soil product for all types cultivators. The formulations are a proprietary all-natural essential oil insecticide/miticide/nematicide that repels and kill a wide variety of pests commonly known to damage cannabis crops.

Nature-Cide products are listed on the “Approved for use in the Cultivation of Marijuana” by the Colorado, Washington and Oregon state Agriculture Departments. The listing is supported by Med-X’s 18-Month Nature-Cide Integrated Pest Management (IPM) for Cannabis Cultivation Report released in March.

“The 18-month report began in 2015 shortly after realizing that the Nature-Cide pesticide products were being recognized by multiple state agricultural departments as a product that is approved for use in medical and recreational marijuana cultivation,” said Mills.

 

Growth advantage

 The legal cannabis industry grew 30 percent in 2016 in North America alone to reach to $6.7 billion because of high growth prospects in the U.S. and Canada, data from Arcview Market Research showed. Arcview is projecting a 25 percent annual growth rate with sales in North American reaching $20.2 billion by 2021.

Med-X is in great position to take advantage of the opportunities in the legal cannabis space.

While primarily in the business of research and development of commercial medicinal applications of cannabis, Med-X Inc. plans to address other needs required to support the fast-paced emerging cannabis industry, including compound identification and extraction from cannabis oils, along with pharmacy automation beginning with cannabis products and eventually for various pharmaceuticals.

According to its SEC filings, Med-X Inc. plans to cultivate and sell high-quality cannabis for the consumer and commercial markets in areas where it is legal and when they are fully licensed to do so.

“Due to our management’s hands-on background in the fields of medicine, large-scale cultivation, commercial pest management as well as operations in internet-based wholesale and retail outlets, we feel we have a tremendous advantage, and can use that skill set to climb into a growth position more rapidly than most,” said Mills.

 

About Med-X, Inc.

 Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compound for the present medical industry demand. The company’s digital magazine, The Marijuana Times, publishes quality media content for the medical cannabis community to generate revenue from advertisers as well as sell industry related merchandise to consumers. The company is ready to bring various products to market in the cannabis, agricultural and ancillary services industries through manufacturing partnerships. For more information regarding Med-X, Inc., please visit www.medx-rx.com, email info@medx-rx.comor call 818-349-2870.

 

Checkout Unique Finance and get a bonus from me.

Why Stocks Remain At The All Time High

Stocks Remain Strong

Despite some hit and miss earning reports, the markets have changed very little from the record setting highs they set last week. Although there have been some worries amongst investors and analysts, the mass majority believe the highs are here to stay for quite some time. There will undoubtedly be dips from time to time and these will prove to be good opportunities for investors to enter the markets. However, some suggest buying in at all-time highs would not be a good idea, since many stocks may have very well hit the ceiling. So, why have stocks remained so high, despite the decreasing prices of crude oil? Well, it could have something to do with the recent earning reports.

Big Companies Feeling the Pain of Gain

Over the course of the week thus far, several big companies have released their earnings. This includes Apple, Comcast, and even McDonald’s. Analysts were initially worried about Apple, due to the slowdown of smartphone sales. A disappointing earnings report would’ve most certainly crashed the market and would have sent stocks tumbling. Nonetheless, Apple had trick up their sleeve and managed to turn a higher-than-expected profit over the past three months. The company’s cheaper smartphone has proven to be a success and managed to push their revenue above that of what analysts expected. Comcast has done the same.

Comcast Casting a Shadow on Success

The company, which is primarily known for its Internet, telephone, and television packages, has dipped its feet into new waters as of late. Nonetheless, it is their core business, which has helped to push them to higher and higher revenues for the past quarter. Comcast’s earnings were impressive and they’ve managed to help rally markets. Thanks to the company’s success, the stock has climbed as much as 1% thus far and could very well climb higher. Despite the good news, the company’s video customer count has continued to drop. During the 2nd quarter, the company lost approximately 4,000 video customers. Nonetheless, this loss was greatly overshadowed by the gain of 220,000 new Internet subscribers

Electricity and Natural Gas

And how about WEC Energy Group? The company is not known for delivering surprises, but they’ve managed to do just that for the last quarter. The Milwaukee-based company, which provides consumers with natural gas and electricity, was recently caught out in the cold, due to the decrease of commodity prices. Nonetheless, the company’s recent moves have helped them turn over revenues, which they’ve never seen before and which analysts did not expect. Most experts agree that company’s recent Integrates acquisition helped them beat earnings. Unfortunately, the company missed revenues and this has sent the stock down to some degree.

The Need for Clean Power

One thing that may hinder the company’s ability in the future is the Clean Power Act. How will they meet emission requirements? Thankfully, the company has worked diligently over the past few years and has already purchased CO2 emissions down 23%. So, why exactly are stocks maintaining their all-time highs? The answer is easy enough, but few will believe it. Despite the conjecture of many analysts and politicians, the American economy is on the rebound. So, you shouldn’t be surprised to see stocks climbing even higher in the coming weeks.

Summary – Stocks have climbed to record highs and have refused to budge. Will they remain there and why? Check out this article to find out.

iTeknik Holding Corporation (OTC: ITKH) in Acquisition Talks with TransMedia Group

 

 

The awarding winning, multi-lingual international PR firm TransMedia Group (www.transmediagroup.com) said it is in discussions to be acquired by a public company, iTeknik Holding Corporation (OTC PINK: ITKH).

Serving clients worldwide since 1981, TransMedia Group has the strong market presence, brand awareness, talented and dedicated staff that iTeknik finds attractive, said TransMedia Group CEO Tom Madden.

 

iTeknik is in the process of implementing a strategy

iTeknik said it’s expanding its acquisition strategy to include PR after meeting Madden, the “Spin Man” himself, and seeing the amazing success his PR firm TransMedia Group (www.transmediagroup.com) has had in helping its clients to grow and prosper.

iTeknik (www.iTeknik.com) is in the process of implementing a strategy to acquire fundamentally sound companies that are market accepted, scalable and demonstrate a quantifiable value proposition.

 

“Until recently, our focus has been to acquire companies involved in marketing, advertising and digital media, but after meeting Madden and his stellar staff, we’ve added PR to the mix and were now in discussions with TransMedia Group in that regard,” said Fred Wicks, Chairman and CEO of iTeknik.

“We could provide TransMedia Group with exemplary marketing, advertising and digital services for its clients.”

 

 Press Release

 

Tom Madden founder of TransMedia Group in New York City

Image result

 

Madden founded TransMedia Group in New York City soon after he left NBC, where he was Vice President, Assistant to the President, then Fred Silverman, for whom he worked previously at American Broadcasting Companies.

Among TransMedia’s first clients were AT&T, Kellogg’s, Drexel Burnham Lambert and the City of New York, for whom TransMedia created award-winning PR campaigns, one promoting fair housing in the city that earned TransMedia a coveted Bronze Anvil Award from the Public Relations Society of America.

TransMedia helps client companies sell for billions.

In 1987, Madden relocated the firm to South Florida where today it operates out of a commercial building Madden owns in downtown Boca Raton.  One of his former clients, Carl DeSantis credits TransMedia’s publicity for increasing the nutritional supplement company’s revenues from $150 million to over $900 million until DeSantis sold the public company for $1.6 billion.  TransMedia’s publicity helped the stock of another DeSantis company, Celsius Holdings Inc. (CELH:US) to rise from $ .30 to $5.00.  The company today is on NASDAQ CM.

One of TransMedia’s growth areas is its newly-established talent and modeling division, TransMediaVersatileTalent (TVT), which currently is signing many celebrities whom it will represent as their agent and manager.  For rising talent Lynn Aronberg, TransMedia arranged for her to be in the cast of  upcoming reality show, Palm Beach Housewives after booking her for interviews on FOX TV, Inside Edition and with Wasington Post and other media outlets worldwide.

Madden said he is impressed how iTeknik’s revenues are expanding.  iTeknick’s revenues for the year ending June 30, 2017 were $1,144,925 vs. $952,149 for the year ending June 30, 2016.

iTeknik has transitioned from the Telecom industry to Marketing, Advertising and the digital media space with the start-up of its Big Rhino Agency in January, which was able to increase its revenues by more than a hundred percent, said Madden.

Wicks said he is looking to acquire companies that have the potential to achieve exceptional performance over time with a focus on the Marketing, Advertising and Digital Media and now the Public Relations space.

iTeknik lends its operational support, management approach and financial resources to these companies to help them achieve improvements in revenue, earnings growth and positioning in the marketplace.

 

iTeknik currently operates Big Rhino Corporation as a wholly owned subsidiary, while actively seeking additional acquisitions.

Big Rhino Corporation, a startup in January 2017, has increased its revenues by 101% through August.  It has expanded its business in Las Vegas by adding several automotive clients to its existing Arizona and California dealerships.  Big Rhino has also diversified into the medical and real estate markets.

“Our strategy is to tap the synergy among these acquisitions to maximize organic growth, improve profitability and leverage client and supplier relationships,” Wicks said.

Wicks has substantial experience in marketing, holding positions such as Editorial Director for Creative Universal, Director of Marketing Services for a $3 billion division of Rockwell International Corporation and worldwide  marketing responsibility for a $400 million division of  Invensys Air Systems.

 

Wicks Marketing Group founded in 1990

He was also the CEO and President of The Wicks Marketing Group, Inc., a consulting company that he founded in 1990. He is a former Senior Vice President with the CompAir Division of Invensys Air Systems, where he had P & L responsibility for $200 million in European and South American businesses.

Wicks also had responsibility for world-wide product management and engineering. He has a Bachelor of Arts in Journalism and an MBA degree from Wayne State University in Michigan

      Learn more about TransMedia rated as the “BEST PR FIRM IN SOUTH FLORIDA”

 

 

TransMedia Group’s Talent Division

Provides Oomph To Its PR Campaigns

For more information: contact Adrienne Mazzone 561-702-4999; amazzone@transmediagroup.com.

 

 

Blood cell regeneration: Hemogenyx’s (LSE: HEMO) revolutionary way to treat leukemia

 

 

Will London Stock Exchange listed (Hemogenyx Pharmaceuticals (LON: HEMO) be the industry game changer we have all been waiting and hoping for?

 

The vitality of the blood stream and the unimpeded way that it circulates through our different physiological systems is one major factor that determines our health. So do the various elements in it, such as the oxygen it carries, or the red and white corpuscles that compose it. An unhealthy blood stream, filled with toxins, or a clogged distribution system that fails to distribute adequate amounts of it to our veins and organs, can weaken our resistance, hamper our lifestyle, and make us vulnerable to illnesses.  Patients of leukemia know of this situation firsthand and struggle with this condition every single day. As described by Medical News Today this illness is a cancer of the blood or the blood marrow, both of which are afflicted with an overproduction of white blood cells. These unhealthy white cells duplicate at an accelerated rate and end up crowding out the healthy ones and even cause their rapid elimination.

Leukemia’s deadly rise

The elimination of the healthy white blood cells that are responsible for strengthening a person’s immune system thus makes them weak and susceptible to many illnesses. Their  body’s natural ability to fight off infection also decreases. Soon, they will have a hard time breathing and, in the absence or significant reduction of healthy red blood cells, their skin pallor will change to pale or deathly white. Other symptoms and signs of leukemia include the following: chills, continual flu, night sweats, pain in the bone structure, perpetual fatigue, and weight loss.

According to Indie Gogo, an estimated 150,000 individuals in the United States alone will be diagnosed with this debilitating illness. Hemogenyx Pharmaceuticals (LON: HEMO), a dynamic healthcare and medical research company that is pioneering more breakthrough treatments of leukemia, places the total number of Americans suffering the illness at more than one million.

 

Where current treatments fail

Hemogenyx also points out the inadequacy of the current treatment being given to these patients. The transplant of a healthier bone marrow, uncontaminated by the non-stop duplication of white cancer cells, is the usual medical response to alleviate leukemia patients of their condition. It is regarded that once the ailing and weakened bone marrow is replaced by one that has all the right red and blood cells, and none of the cancerous production, the patient’s body will stop suffering the onslaught of the lethal cancer cell replication. The right amount of red and white cells in the bone marrow will also correct his physiological system.

Unfortunately, while well-intentioned and popular, the bone marrow transplant carries its own intrinsic flaw, which sometimes cannot serve certain patients in the long run. According to Hemogenyx’s own research, there is an acute shortage of bone marrow donors who will make the transplant possible. Only 60 percent of the entire number of patients can find a suitable donor. Then, assuming that the hospital or medical center does reach one and can facilitate the transplant, 50 percent of the cases fail after the operation.

The reasons usually have to do with the compatibility of the donated organ and the patient’s own physiological system. This failure rate is high and can leave the patient worse off than before; not only did the transplanted bone marrow not work, but their entire physiological system has been made weaker. They also lost a significant number of days in their life that could have been better spent enhancing it. Worse, they may not have enough strength to withstand another bone marrow transplant, which effectively reduces their chances for healing and recovery.

 

 

                                 Groundbreaking Discovery for the Treatment of Leukemia     

The above-mentioned common and sad scenario makes the revolutionary technique discovered by Hemogenyx even more ground-breaking. The company is changing the way bone marrow transplants are done to the point that it may even replace chemotherapy. 

First,

All the one element that will make the patient’s treatment and recovery possible comes from their own body. Compatibility with another person’s donated organ or tissue then no longer becomes an issue.

Second,

The key to the patient’s healing is also a bunch of cells, known as the Adult Hemogenic Endothelium (AHE), that can be found in the microscopic blood cells of grownups.

Third,

The AHE cells can be tapped to regenerate and revitalize the ailing patient’s entire blood system and not merely be used to combat the production of unhealthy blood cells.

Dr. Vladislav Sandler

This discovery was made by Dr. Vladislav Sandler in 2012, and Hemogenyx has since then been pushing it towards  Phase 1 Clinical trials. A brilliant scientist, Dr. Sandler led Hemogenyx in winning the prestigious 43North, the largest business competition in the world with over 7,000 entrants. He discovered the AHE cells in the body that were previously thought to disappear at birth. Also known as postnatal human hemogenic endothelial cells (Hu-PHEC cells), they are either taken from the umbilical cord and placenta or the patient’s liver biopsy.

A replacement for chemotherapy

To date, the procedure sounds simpler and more convenient than the conventional bone marrow transplant. The doctor can easily track down the AHE cells that are present in the patient’s own organs such as their liver. A simple biopsy can remove and isolate these cells from their original location and then prepare them for transplant. These cells are not dangerous nor malignant; neither do they contain the mutations that lead to the cancerous cell production that leads to leukemia. What seems to be “miraculous” about them is that they rejuvenate the patient’s entire blood stream.

Science-Fiction Analogy

To use a science-fiction analogy, the bone marrow transplant is similar to attaching an alien machine component to one’s arm after the limb has been severed. The cybernetic arm may fit and function, or it may not. But the treatment of Hemogenyx is like growing a new, stronger arm where one had been accidentally cut off. Once it reaches full growth, it will look natural on the owner—because it is natural and came from them.  Hemogenyx’s technology has the potential to replace chemotherapy and eliminate the side effects that come with it. It also has the flexibility of being applied to other blood diseases such as HIV, sepsis, multiple myeloma, and others.

 

Hemogenyx’s new treatment does not just save patients’ lives; in reinvigorating their blood stream, it might as well have given them a new one.